Clinical trial

Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)

NCT00453921 · Dartmouth-Hitchcock Medical Center, Other · Completed

Key facts

NCT number NCT00453921
Title Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Official title Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Lead sponsor Dartmouth-Hitchcock Medical Center, Other
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Study type Interventional
Conditions Brain Injury
Intervention type Behavioral, Drug, Other
Interventions Methylphenidate, Memory and Attention Training, Placebo as both treatments
Enrollment 76
Start date Feb 1, 2007
Primary completion May 1, 2013
Completion May 1, 2013
First posted Mar 29, 2007
Last update posted Jun 13, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies